Skip to main content
Table of Contents
Print

Are there any new cannabis-based medications in development for fibromyalgia? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

The search for better fibromyalgia  treatments has brought cannabis-based medication into focus. With many patients seeking alternatives to traditional therapies that may fall short or carry unwanted side effects, pharmaceutical innovation is exploring more precise, effective options rooted in cannabis science. 

Emerging cannabis-based therapies 

Here’s a breakdown of what’s currently surfacing in pharma development for fibromyalgia relief: 

Nabilone and synthetic cannabinoids 

Nabilone is a laboratory-made cannabinoid that mimics THC’s effects with controlled dosing. It’s being tested for its potential to ease fibromyalgia symptoms such as pain and disrupted sleep. This makes it a promising candidate among new treatment avenues. 

Terpene-focused formulations 

Specific terpenes like beta-caryophyllene, linalool, and geraniol are under investigation for their anti-inflammatory and calming properties. These compounds could deliver new treatment options that avoid psychoactive effects, offering an alternative route for symptom control. 

Precision delivery systems 

Innovations include sublingual sprays and oral dissolvable tablets engineered for consistent, accurate dose delivery. By reducing variability in absorption, these tools support patient safety and improve treatment reliability. 

Combination therapies 

Some new treatments combine cannabis-based medication with other drugs like antidepressants or muscle relaxants. The idea is to target multiple symptoms while using lower doses of each treatment to reduce side effects. 

Clinical trial expansion 

Larger, more rigorous trials are anticipated to assess cannabis-based therapies across diverse fibromyalgia symptoms from chronic pain and fatigue to mood and sleep quality. 

While fully approved cannabis medications for fibromyalgia remain limited, the momentum behind pharma development is encouraging. Emerging therapies, from synthetic cannabinoids and terpene blends to smart delivery formats show promise in delivering tailored, safer, and more accessible care. 

As research progresses, these new treatment possibilities may soon reshape how fibromyalgia is managed, offering genuine hope to patients seeking meaningful relief. 

If you’re exploring cannabis treatment options for fibromyalgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Fibromyalgia .

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories